European Diabetic Retinopathy Market poised to grow tremendously during forecast period 2016-2021.

Market Data Forecast has published a new report “Europe Diabetic Retinopathy Market”, according to which the market is estimated at $6.1 million in 2016 and poised to grow $8.52 million by 2021 with a CAGR of 6.9% in the forecast period.

Diabetic retinopathy is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissues i.e. retina. Diabetes if not treated with timely monitoring of blood sugar causes multiple-organ failure. Eyes are one of the most prone areas that are affected by diabetes. Diabetes retinopathy is one of the leading causes of blindness in old age population.

Diabetes retinopathy progresses though four stages namely Mild nonproliferative retinopathy, Moderate nonproliferative retinopathy, severe nonproliferative retinopathy and Proliferative diabetic retinopathy. For treatment of retinopathy, any new techniques such as laser treatment VEFG drugs etc. have been introduced and are being tested. The market for diabetic retinopathy is bound to increase due to increasing cases of diabetes in age group of 30-50.

The report provides a detailed analysis of drivers and constraints that controls growth of the market. Some of the drivers are:
• Increasing cases of diabetes in geriatric population.
• Lifestyle changes causing diabetes at early age.
• Increasing awareness among the masses regarding different drugs and therapies.

For Full Report refer to: http://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/

For better understanding Diabetic Retinopathy Market is segmented by type of treatment, indication and end-user. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.

The Europe Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are predicted to propel the growth of non-proliferative diabetic retinopathy market share.

Free Sample for report: http://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/request-sample
Geographically, European market is segmented into, Spain, Germany, France, Italy and UK. Europe holds the largest amount of shares over the world for diabetic retinopathy market.

The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc. Pfizer has collaborated with Eyecyte and invested $3 million in its R&D to develop new medicines.

Customization option available at: http://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/customize-report

The Europe Diabetic Retinopathy Market report offers wide-range of scope:

• Regional and country-level analysis that provides an individual perspective of European region and the aforementioned countries

• Know more about key areas of industry growth via detailed Segment-level analysis on basis of type of treatment, indication and end-user along with market size forecasts and y-o-y estimations

• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics

• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics

• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview

• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.

Enquire about the report: http://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/inquire

Checkout other related studies in the Therapeutics Segment:

Hormone Replacement Therapy Market: http://www.marketdataforecast.com/market-reports/global-hormone-replacement-therapy-market-957/

Kidney Cancer Diagnostics and Therapeutics Market: http://www.marketdataforecast.com/market-reports/global-kidney-cancer-diagnostics-and-therapeutics-market-843/

Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/

Ophthalmology Therapeutics Market: http://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/

About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Jubilee Gardens,
Hyderabad, India.

This release was published on openPR.